{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-050796","form_type":"8-K","ticker":"ADCT","cik":"0001771910","company_name":"ADC Therapeutics SA","filed_at":"2025-11-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.385487+00:00","generated_at":"2026-05-16T22:31:30.381822+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"ADC Therapeutics Q3 net product revenue $15.8M; net loss narrows to $41M; $60M PIPE strengthens cash","bullets":["Q3 net product revenue $15.8M (down 12% YoY); nine-month 2025 revenue $51.2M vs $52.9M in 2024.","Net loss $41.0M ($0.30 per share) vs $44.0M ($0.42) in Q3 2024; adjusted net loss $25.5M ($0.19).","Completed $60M PIPE financing with $57.6M net proceeds; pro forma cash $292.3M to support ZYNLONTA expansion.","LOTIS-7 updated data by end of 2025; LOTIS-5 topline data expected 1H 2026; FL IIT shows ORR 98.2%, CR 83.6%.","IND-enabling for PSMA-targeting ADC to be completed by end of 2025; restructuring costs $13.5M YTD."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-050796","json":"https://secwatch.observer/filing/0001628280-25-050796.json","markdown":"https://secwatch.observer/filing/0001628280-25-050796.md","text":"https://secwatch.observer/filing/0001628280-25-050796.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1771910/000162828025050796/0001628280-25-050796-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1771910/000162828025050796/adc-20251110.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T22:31:30.381822+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}